International Journal of Molecular Sciences (Sep 2022)

Replication of Human Norovirus in Mice after Antibiotic-Mediated Intestinal Bacteria Depletion

  • Cristina Santiso-Bellón,
  • Roberto Gozalbo-Rovira,
  • Javier Buesa,
  • Antonio Rubio-del-Campo,
  • Nazaret Peña-Gil,
  • Noemi Navarro-Lleó,
  • Roberto Cárcamo-Calvo,
  • María J. Yebra,
  • Vicente Monedero,
  • Jesús Rodríguez-Díaz

DOI
https://doi.org/10.3390/ijms231810643
Journal volume & issue
Vol. 23, no. 18
p. 10643

Abstract

Read online

Human noroviruses (HuNoVs) are the main cause of acute gastroenteritis causing more than 50,000 deaths per year. Recent evidence shows that the gut microbiota plays a key role in enteric virus infectivity. In this context, we tested whether microbiota depletion or microbiota replacement with that of human individuals susceptible to HuNoVs infection could favor viral replication in mice. Four groups of mice (n = 5) were used, including a control group and three groups that were treated with antibiotics to eliminate the autochthonous intestinal microbiota. Two of the antibiotic-treated groups received fecal microbiota transplantation from a pool of feces from infants (age 1–3 months) or an auto-transplantation with mouse feces that obtained prior antibiotic treatment. The inoculation of the different mouse groups with a HuNoVs strain (GII.4 Sydney [P16] genotype) showed that the virus replicated more efficiently in animals only treated with antibiotics but not subject to microbiota transplantation. Viral replication in animals receiving fecal microbiota from newborn infants was intermediate, whereas virus excretion in feces from auto-transplanted mice was as low as in the control mice. The analysis of the fecal microbiota by 16S rDNA NGS showed deep variations in the composition in the different mice groups. Furthermore, differences were observed in the gene expression of relevant immunological mediators, such as IL4, CXCL15, IL13, TNFα and TLR2, at the small intestine. Our results suggest that microbiota depletion eliminates bacteria that restrict HuNoVs infectivity and that the mechanism(s) could involve immune mediators.

Keywords